This company has been marked as potentially delisted and may not be actively trading. Rain Oncology (RAIN) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsHeadlinesInsider TradesTrendsBuy This Stock RAIN vs. CGBS, HUDA, ALCY, SELX, NBST, CLRC, BUJA, TBMC, IRAA, and HSPOShould you be buying Rain Oncology stock or one of its competitors? The main competitors of Rain Oncology include Crown LNG (CGBS), Hudson Acquisition I (HUDA), Alchemy Investments Acquisition Corp 1 (ALCY), Semilux International (SELX), Newbury Street Acquisition (NBST), ClimateRock (CLRC), Bukit Jalil Global Acquisition 1 (BUJA), Trailblazer Merger Co. I (TBMC), Iris Acquisition (IRAA), and Horizon Space Acquisition I (HSPO). These companies are all part of the "holding & other investment offices" industry. Rain Oncology vs. Crown LNG Hudson Acquisition I Alchemy Investments Acquisition Corp 1 Semilux International Newbury Street Acquisition ClimateRock Bukit Jalil Global Acquisition 1 Trailblazer Merger Co. I Iris Acquisition Horizon Space Acquisition I Rain Oncology (NASDAQ:RAIN) and Crown LNG (NASDAQ:CGBS) are both small-cap business services companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, profitability, media sentiment, risk, valuation, institutional ownership, analyst recommendations, earnings and community ranking. Does the media favor RAIN or CGBS? In the previous week, Crown LNG's average media sentiment score of 0.00 beat Rain Oncology's score of -0.29 indicating that Crown LNG is being referred to more favorably in the news media. Company Overall Sentiment Rain Oncology Neutral Crown LNG Neutral Which has stronger valuation and earnings, RAIN or CGBS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRain OncologyN/AN/A$3.10MN/AN/ACrown LNGN/AN/A-$6.19M-$0.87-0.14 Is RAIN or CGBS more profitable? Company Net Margins Return on Equity Return on Assets Rain OncologyN/A N/A -9.51% Crown LNG N/A N/A N/A Which has more risk and volatility, RAIN or CGBS? Rain Oncology has a beta of -0.11, suggesting that its share price is 111% less volatile than the S&P 500. Comparatively, Crown LNG has a beta of 0.02, suggesting that its share price is 98% less volatile than the S&P 500. Does the MarketBeat Community believe in RAIN or CGBS? Rain Oncology received 26 more outperform votes than Crown LNG when rated by MarketBeat users. CompanyUnderperformOutperformRain OncologyOutperform Votes2652.00% Underperform Votes2448.00% Crown LNGN/AN/A Do insiders and institutionals believe in RAIN or CGBS? 25.8% of Rain Oncology shares are held by institutional investors. Comparatively, 21.9% of Crown LNG shares are held by institutional investors. 17.4% of Rain Oncology shares are held by company insiders. Comparatively, 38.5% of Crown LNG shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. SummaryCrown LNG beats Rain Oncology on 4 of the 7 factors compared between the two stocks. Get Rain Oncology News Delivered to You Automatically Sign up to receive the latest news and ratings for RAIN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RAIN vs. The Competition Export to ExcelMetricRain OncologyHolding Offices IndustryBusiness SectorNASDAQ ExchangeMarket Cap$16.01M$460.51M$7.13B$7.74BDividend YieldN/A8.06%2.65%4.32%P/E RatioN/A2.3730.5918.24Price / SalesN/A56.26157.09104.73Price / Cash7.4169.0131.5134.62Price / Book-4.193.634.774.19Net Income$3.10M$35.22M$195.87M$247.59M Rain Oncology Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RAINRain OncologyN/A$2.89+3.6%N/AN/A$16.01MN/A0.0063CGBSCrown LNGN/A$0.12-16.8%N/AN/A$56.79MN/A-0.145HUDAHudson Acquisition IN/A$12.56flatN/AN/A$56.52MN/A0.00N/AHigh Trading VolumeALCYAlchemy Investments Acquisition Corp 1N/A$12.36+8.9%N/A+7.2%$56.01MN/A0.00N/ANews CoverageSELXSemilux International0.8536 of 5 stars$1.49+3.9%N/A-2.6%$55.63M$32.84M0.0058Gap DownNBSTNewbury Street AcquisitionN/A$11.10flatN/AN/A$54.93MN/A0.002CLRCClimateRockN/A$12.05+0.3%N/A+5.8%$54.83MN/A0.002BUJABukit Jalil Global Acquisition 1N/A$10.79-3.2%N/A+2.3%$53.31MN/A0.00N/APositive NewsTBMCTrailblazer Merger Co. IN/A$11.41+0.5%N/A+6.3%$51.31MN/A0.00N/APositive NewsIRAAIris AcquisitionN/A$7.00flatN/A-49.7%$49.97MN/A0.00N/AHSPOHorizon Space Acquisition IN/A$11.79-1.7%N/A+7.8%$49.15MN/A0.002Positive News Related Companies and Tools Related Companies Crown LNG Competitors Hudson Acquisition I Competitors Alchemy Investments Acquisition Corp 1 Competitors Semilux International Competitors Newbury Street Acquisition Competitors ClimateRock Competitors Bukit Jalil Global Acquisition 1 Competitors Trailblazer Merger Co. I Competitors Iris Acquisition Competitors Horizon Space Acquisition I Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:RAIN) was last updated on 4/25/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredTrump purposefully forcing markets to crash…Whether you agree with the plan or not doesn’t matter. It’s happening. The only question is – are you re...Porter & Company | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rain Oncology Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rain Oncology With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy RAIN Stock Free RAIN Stock Alerts